Track the 코스맥스비티아이 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 코스맥스비티아이 has recorded 55 public disclosures. Market capitalisation: €191.6bn. The latest transaction was disclosed on 26 June 2026 (Other). Among the most active insiders: 서성석. All data is accessible without an account.
55
Insider Decl.
n/a
Thresholds
n/a
41 ops.
Buy Volume
n/a
2 ops.
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 13,075 of 28,065 companies
53.8
score / 100
Value
67
Quality
40
FCF yld1.1%
Earn yld13%
EV/EBITDA9.4x
ROE13%
Gross mgn21%
Net mgn4.5%
Debt/EBITDA6.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Cosmax BTI is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and manufacturing of pharmaceutical and cosmetic products.